These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33045385)
1. Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis. Dehn J; Chitphakdithai P; Shaw BE; McDonald AA; Devine SM; Burns LJ; Spellman S Transplant Cell Ther; 2021 Feb; 27(2):184.e1-184.e13. PubMed ID: 33045385 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation. Acevedo MJ; Wilder JS; Adams S; Davis J; Kelly C; Hilligoss D; Carroll E; Blacklock-Schuver B; Cole K; Kang EM; Hsu AP; Kanakry CG; Dimitrova D; Kanakry JA Biol Blood Marrow Transplant; 2019 Aug; 25(8):1666-1673. PubMed ID: 30986499 [TBL] [Abstract][Full Text] [Related]
3. Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program. Pidala J; Mupfudze TG; Payton T; Barker J; Perales MA; Shaw BE; Fernández-Viña M; Burns LJ; Dehn J Biol Blood Marrow Transplant; 2019 Dec; 25(12):2501-2506. PubMed ID: 31419569 [TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Opting Out of an Unrelated Hematopoietic Stem Cell Donor Registry: Differences and Similarities across Five Key Groups of Young Race/Ethnically Diverse Potential Donors in the United States. Hamed AB; Bruce JG; Kuniyil V; Ahmed N; Mattila D; Williams EP; Dew MA; Myaskovsky L; Confer DL; Switzer GE Transplant Cell Ther; 2024 May; 30(5):512.e1-512.e15. PubMed ID: 38365082 [TBL] [Abstract][Full Text] [Related]
5. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products. Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis. Arnold SD; Brazauskas R; He N; Li Y; Hall M; Atsuta Y; Dalal J; Hahn T; Khera N; Bonfim C; Hashmi S; Parsons S; Wood WA; Steinberg A; Freytes CO; Dandoy CE; Marks DI; Lazarus HM; Abdel-Azim H; Bitan M; Diaz MA; Olsson RF; Gergis U; Seber A; Wirk B; LeMaistre CF; Ustun C; Duncan C; Rizzieri D; Szwajcer D; Fagioli F; Frangoul H; Knight JM; Kamble RT; Mehta P; Schears R; Satwani P; Pulsipher MA; Aplenc R; Saber W Biol Blood Marrow Transplant; 2020 Sep; 26(9):1747-1756. PubMed ID: 32464284 [TBL] [Abstract][Full Text] [Related]
7. The National Marrow Donor Program: improving access to hematopoietic cell transplantation. Walker T; Milford E; Chell J; Maiers M; Confer D Clin Transpl; 2011; ():55-62. PubMed ID: 22755401 [TBL] [Abstract][Full Text] [Related]
8. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. Gragert L; Eapen M; Williams E; Freeman J; Spellman S; Baitty R; Hartzman R; Rizzo JD; Horowitz M; Confer D; Maiers M N Engl J Med; 2014 Jul; 371(4):339-48. PubMed ID: 25054717 [TBL] [Abstract][Full Text] [Related]
9. Chances of Finding Matched Unrelated Donors for Saudi Patients in Need of Hematopoietic Stem Cell Transplantation. Jawdat D; Almutairi Y; Almutairi Z; Almusa A; Hajeer A Transplant Cell Ther; 2021 May; 27(5):423.e1-423.e7. PubMed ID: 33781751 [TBL] [Abstract][Full Text] [Related]
10. Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely. Olson JA; Gibbens Y; Tram K; Kempenich J; Novakovich J; Buck K; Dehn J HLA; 2017 Feb; 89(2):77-81. PubMed ID: 28102042 [TBL] [Abstract][Full Text] [Related]
11. Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method. Dubois V; Detrait M; Sobh M; Morisset S; Labussière H; Giannoli C; Nicolini F; Moskovtchenko P; Mialou V; Ducastelle S; Rey S; Thomas X; Barraco F; Tedone N; Marry E; Garnier F; Bertrand Y; Michallet M Hum Immunol; 2016 Nov; 77(11):1008-1015. PubMed ID: 26902994 [TBL] [Abstract][Full Text] [Related]
12. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program. Karanes C; Confer D; Walker T; Askren A; Keller C Oncology (Williston Park); 2003 Aug; 17(8):1036-8, 1043-4, 1164-7. PubMed ID: 12966671 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550 [TBL] [Abstract][Full Text] [Related]
14. High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry. Buck K; Wadsworth K; Setterholm M; Maiers M; Confer D; Hartzman R; Schmidt A; Yang SY; Dehn J Biol Blood Marrow Transplant; 2016 Apr; 22(4):759-763. PubMed ID: 26724431 [TBL] [Abstract][Full Text] [Related]
16. Impact of Ethnicity on Donor Search Results for Children Requiring Stem Cell Transplantation. DiLabio J; Doyle J; Alexander S; Gupta S; Punnett A J Pediatr Hematol Oncol; 2015 Apr; 37(3):e154-7. PubMed ID: 25333838 [TBL] [Abstract][Full Text] [Related]
17. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation. Confer D; Robinett P Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S3-S5. PubMed ID: 18724295 [TBL] [Abstract][Full Text] [Related]
18. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission. Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881 [TBL] [Abstract][Full Text] [Related]
19. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Dehn J; Spellman S; Hurley CK; Shaw BE; Barker JN; Burns LJ; Confer DL; Eapen M; Fernandez-Vina M; Hartzman R; Maiers M; Marino SR; Mueller C; Perales MA; Rajalingam R; Pidala J Blood; 2019 Sep; 134(12):924-934. PubMed ID: 31292117 [TBL] [Abstract][Full Text] [Related]
20. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program. Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]